Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 112.25 Million USD | -0.96% |
| 2022 | 113.33 Million USD | -4.68% |
| 2021 | 118.9 Million USD | 16.46% |
| 2020 | 102.1 Million USD | -12.12% |
| 2019 | 116.17 Million USD | -3.81% |
| 2018 | 120.77 Million USD | 18.54% |
| 2017 | 101.88 Million USD | -2.52% |
| 2016 | 104.52 Million USD | -3.81% |
| 2015 | 108.66 Million USD | 0.0% |
| 2014 | 108.66 Million USD | 3.32% |
| 2013 | 105.17 Million USD | -5.4% |
| 2012 | 111.17 Million USD | 2.12% |
| 2011 | 108.86 Million USD | 0.63% |
| 2010 | 108.17 Million USD | 26.12% |
| 2009 | 85.77 Million USD | -2.59% |
| 2008 | 88.04 Million USD | 5.57% |
| 2007 | 83.4 Million USD | 9.49% |
| 2006 | 76.18 Million USD | 12.98% |
| 2005 | 67.43 Million USD | -27.18% |
| 2004 | 92.59 Million USD | 6.26% |
| 2003 | 87.14 Million USD | 51.87% |
| 2002 | 57.38 Million USD | 40.4% |
| 2001 | 40.86 Million USD | 33.67% |
| 2000 | 30.57 Million USD | 16.8% |
| 1999 | 26.17 Million USD | 115.38% |
| 1998 | 12.15 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 24.51 Million USD | -12.93% |
| 2024 Q2 | 23.09 Million USD | -5.77% |
| 2023 Q3 | 25.36 Million USD | -11.81% |
| 2023 FY | 112.25 Million USD | -0.96% |
| 2023 Q1 | 29.97 Million USD | 5.45% |
| 2023 Q4 | 28.15 Million USD | 11.0% |
| 2023 Q2 | 28.75 Million USD | -4.06% |
| 2022 Q4 | 28.42 Million USD | 5.59% |
| 2022 FY | 113.33 Million USD | -4.68% |
| 2022 Q3 | 26.92 Million USD | -7.83% |
| 2022 Q2 | 29.2 Million USD | 1.49% |
| 2022 Q1 | 28.77 Million USD | -12.94% |
| 2021 Q4 | 33.05 Million USD | 11.44% |
| 2021 Q1 | 26.98 Million USD | -12.89% |
| 2021 Q3 | 29.66 Million USD | 1.6% |
| 2021 Q2 | 29.19 Million USD | 8.18% |
| 2021 FY | 118.9 Million USD | 16.46% |
| 2020 Q3 | 24.03 Million USD | 3.13% |
| 2020 Q4 | 30.98 Million USD | 28.9% |
| 2020 FY | 102.1 Million USD | -12.12% |
| 2020 Q1 | 23.77 Million USD | -79.54% |
| 2020 Q2 | 23.3 Million USD | -1.95% |
| 2019 FY | 116.17 Million USD | -3.81% |
| 2019 Q3 | 27.41 Million USD | -7.32% |
| 2019 Q4 | 116.17 Million USD | 323.72% |
| 2019 Q2 | 29.58 Million USD | 4.9% |
| 2019 Q1 | 28.2 Million USD | -16.71% |
| 2018 FY | 120.77 Million USD | 18.54% |
| 2018 Q1 | 26.75 Million USD | -2.56% |
| 2018 Q3 | 28.63 Million USD | -9.16% |
| 2018 Q4 | 33.85 Million USD | 18.24% |
| 2018 Q2 | 31.52 Million USD | 17.8% |
| 2017 Q1 | 24.15 Million USD | -8.55% |
| 2017 FY | 101.88 Million USD | -2.52% |
| 2017 Q4 | 27.46 Million USD | 9.63% |
| 2017 Q3 | 25.05 Million USD | -0.65% |
| 2017 Q2 | 25.21 Million USD | 4.38% |
| 2016 Q3 | 25 Million USD | -4.32% |
| 2016 Q4 | 26.41 Million USD | 5.63% |
| 2016 Q1 | 26.96 Million USD | -4.96% |
| 2016 FY | 104.52 Million USD | -3.81% |
| 2016 Q2 | 26.13 Million USD | -3.07% |
| 2015 Q1 | 25.76 Million USD | -15.15% |
| 2015 Q3 | 25.73 Million USD | -10.66% |
| 2015 Q4 | 28.37 Million USD | 10.26% |
| 2015 FY | 108.66 Million USD | 0.0% |
| 2015 Q2 | 28.8 Million USD | 11.79% |
| 2014 Q1 | 25.89 Million USD | -7.04% |
| 2014 Q2 | 26.95 Million USD | 4.11% |
| 2014 FY | 108.66 Million USD | 3.32% |
| 2014 Q4 | 30.36 Million USD | 19.32% |
| 2014 Q3 | 25.44 Million USD | -5.6% |
| 2013 FY | 105.17 Million USD | -5.4% |
| 2013 Q4 | 27.85 Million USD | 10.81% |
| 2013 Q3 | 25.13 Million USD | -3.67% |
| 2013 Q2 | 26.09 Million USD | 0.03% |
| 2013 Q1 | 26.08 Million USD | -7.66% |
| 2012 Q3 | 26.1 Million USD | -8.39% |
| 2012 Q4 | 28.24 Million USD | 8.22% |
| 2012 Q1 | 28.32 Million USD | -2.43% |
| 2012 FY | 111.17 Million USD | 2.12% |
| 2012 Q2 | 28.49 Million USD | 0.61% |
| 2011 Q3 | 26.38 Million USD | -2.81% |
| 2011 Q2 | 27.14 Million USD | 3.16% |
| 2011 Q1 | 26.31 Million USD | -10.87% |
| 2011 FY | 108.86 Million USD | 0.63% |
| 2011 Q4 | 29.02 Million USD | 10.03% |
| 2010 Q2 | 25.9 Million USD | -1.5% |
| 2010 Q4 | 29.52 Million USD | 11.6% |
| 2010 FY | 108.17 Million USD | 26.12% |
| 2010 Q3 | 26.45 Million USD | 2.12% |
| 2010 Q1 | 26.3 Million USD | -4.89% |
| 2009 Q2 | 18.04 Million USD | -5.36% |
| 2009 Q1 | 19.07 Million USD | -17.27% |
| 2009 FY | 85.77 Million USD | -2.59% |
| 2009 Q4 | 27.65 Million USD | 31.69% |
| 2009 Q3 | 20.99 Million USD | 16.34% |
| 2008 Q1 | 21.95 Million USD | -10.48% |
| 2008 Q4 | 23.05 Million USD | 15.32% |
| 2008 FY | 88.04 Million USD | 5.57% |
| 2008 Q3 | 19.98 Million USD | -13.28% |
| 2008 Q2 | 23.04 Million USD | 4.96% |
| 2007 Q2 | 20.41 Million USD | 6.77% |
| 2007 Q1 | 19.11 Million USD | -11.84% |
| 2007 Q3 | 19.35 Million USD | -5.18% |
| 2007 FY | 83.4 Million USD | 9.49% |
| 2007 Q4 | 24.52 Million USD | 26.75% |
| 2006 Q4 | 21.68 Million USD | 14.48% |
| 2006 Q2 | 18.18 Million USD | 4.7% |
| 2006 Q1 | 17.37 Million USD | -2.63% |
| 2006 FY | 76.18 Million USD | 12.98% |
| 2006 Q3 | 18.94 Million USD | 4.15% |
| 2005 Q1 | 22.43 Million USD | -9.35% |
| 2005 Q2 | 21.72 Million USD | -3.17% |
| 2005 Q3 | 17.17 Million USD | -20.92% |
| 2005 Q4 | 17.84 Million USD | 3.85% |
| 2005 FY | 67.43 Million USD | -27.18% |
| 2004 Q3 | 23.22 Million USD | 3.4% |
| 2004 Q4 | 24.74 Million USD | 6.57% |
| 2004 Q2 | 22.46 Million USD | 1.33% |
| 2004 Q1 | 22.16 Million USD | -8.44% |
| 2004 FY | 92.59 Million USD | 6.26% |
| 2003 FY | 87.14 Million USD | 51.87% |
| 2003 Q2 | 22.35 Million USD | 14.79% |
| 2003 Q3 | 21.1 Million USD | -5.57% |
| 2003 Q4 | 24.2 Million USD | 14.68% |
| 2003 Q1 | 19.47 Million USD | 3.08% |
| 2002 Q2 | 13.72 Million USD | 14.76% |
| 2002 Q3 | 12.79 Million USD | -6.79% |
| 2002 Q1 | 11.96 Million USD | 0.47% |
| 2002 FY | 57.38 Million USD | 40.4% |
| 2002 Q4 | 18.89 Million USD | 47.62% |
| 2001 Q2 | 9.71 Million USD | 12.83% |
| 2001 Q3 | 10.64 Million USD | 9.6% |
| 2001 FY | 40.86 Million USD | 33.67% |
| 2001 Q1 | 8.6 Million USD | 1.19% |
| 2001 Q4 | 11.9 Million USD | 11.88% |
| 2000 FY | 30.57 Million USD | 16.8% |
| 2000 Q1 | 7.35 Million USD | 0.0% |
| 2000 Q4 | 8.5 Million USD | 15.63% |
| 2000 Q3 | 7.35 Million USD | 0.0% |
| 2000 Q2 | 7.35 Million USD | 0.0% |
| 1999 FY | 26.17 Million USD | 115.38% |
| 1998 FY | 12.15 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -16.161% |
| AngioDynamics, Inc. | 303.91 Million USD | 63.065% |
| AtriCure, Inc. | 399.24 Million USD | 71.884% |
| Avinger, Inc. | 7.65 Million USD | -1366.937% |
| Azenta, Inc. | 665.07 Million USD | 83.122% |
| BioLife Solutions, Inc. | 143.27 Million USD | 21.652% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 96.876% |
| Daxor Corporation | 1.28 Million USD | -8666.004% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -514.093% |
| Femasys Inc. | 1.07 Million USD | -10371.375% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Hologic, Inc. | 4.03 Billion USD | 97.215% |
| ICU Medical, Inc. | 2.25 Billion USD | 95.031% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 98.424% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -293.616% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 41.985% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -9639.874% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -9639.874% |
| Masimo Corporation | 2.04 Billion USD | 94.519% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -15.604% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 91.073% |
| Nephros, Inc. | 14.23 Million USD | -688.383% |
| NovoCure Limited | 509.33 Million USD | 77.962% |
| NEXGEL, Inc. | 4.08 Million USD | -2645.17% |
| NEXGEL, Inc. | 4.08 Million USD | -2645.17% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -3756.063% |
| OraSure Technologies, Inc. | 405.47 Million USD | 72.316% |
| Pro-Dex, Inc. | 53.84 Million USD | -108.473% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -6205.85% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -487.563% |
| QuidelOrtho Corporation | 2.99 Billion USD | 96.256% |
| Repligen Corporation | 638.76 Million USD | 82.427% |
| Sanara MedTech Inc. | 64.98 Million USD | -72.719% |
| STAAR Surgical Company | 322.41 Million USD | 65.185% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -123.499% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 97.169% |
| Jin Medical International Ltd. | 19.82 Million USD | -466.305% |